Interim analysis of the Daliah trial - a randomized controlled phase iii clinical trial Comparing recombinant interferon alpha-2 vs. Hydroxyurea in MPN patients.

Trine Alma Knudsen; Dennis Lund Hansen; Lukas Frans Ocias; Ole Weiss Bjerrum; Mette Brabrand; Daniel El Fassi; Mikael Frederiksen; Lasse Kjær; Thomas Kielsgaard Kristensen; Torben A Kruse; Hans Torben Mourits-Andersen; Peter Møller; Ulrik Malthe  Overgaard; Marianne Tang Severinsen; Vibe Henriette  Skov; Jesper Stentoft; Jørn Starklint; Karin de Stricker; Mads Thomassen; Thomas Stauffer Larsen; Hans Carl  Hasselbalch

Interim analysis of the Daliah trial - a randomized controlled phase iii clinical trial Comparing recombinant interferon alpha-2 vs. Hydroxyurea in MPN patients.

Trine Alma Knudsen, Dennis Lund Hansen, Lukas Frans Ocias, Ole Weiss Bjerrum, Mette Brabrand, Daniel El Fassi, Mikael Frederiksen, Lasse Kjær, Thomas Kielsgaard Kristensen, Torben A Kruse, Hans Torben Mourits-Andersen, Peter Møller, Ulrik Malthe Overgaard, Marianne Tang Severinsen, Vibe Henriette Skov, Jesper Stentoft, Jørn Starklint, Karin de Stricker, Mads Thomassen, Thomas Stauffer LarsenHans Carl Hasselbalch

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

185 Downloads (Pure)

Original language	English
Article number	S131
Journal	HemaSphere
Volume	2
Issue number	S1
Pages (from-to)	18-19
Publication status	Published - 15. Jun 2018
Event	European Hematology Association 23rd congress EHA 2018 - Stockholm , Sweden Duration: 14. Jun 2018 → 17. Jun 2018

Conference

Conference	European Hematology Association 23rd congress EHA 2018
Country/Territory	Sweden
City	Stockholm
Period	14/06/2018 → 17/06/2018

Documents & Links

Interim analysis of the Daliah trial Final published version, 408 MBLicence: CC BY-NC-ND

https://doi.org/10.1097/HS9.0000000000000060Licence: CC BY-NC-ND

SDU Link

Check access to the material in SDU Library's search engine

Cite this

Knudsen, T. A., Lund Hansen, D., Ocias, L. F., Weiss Bjerrum, O., Brabrand, M., El Fassi, D., Frederiksen, M., Kjær, L., Kielsgaard Kristensen, T., Kruse, T. A., Mourits-Andersen, H. T., Møller, P., Overgaard, U. M., Severinsen, M. T., Skov, V. H., Stentoft, J., Starklint, J., de Stricker, K., Thomassen, M., ... Hasselbalch, H. C. (2018). Interim analysis of the Daliah trial - a randomized controlled phase iii clinical trial Comparing recombinant interferon alpha-2 vs. Hydroxyurea in MPN patients. HemaSphere, 2(S1), 18-19. Article S131. https://doi.org/10.1097/HS9.0000000000000060

@article{992c4ff7241d42d5bf3601e5ad9ef7cd,

title = "Interim analysis of the Daliah trial - a randomized controlled phase iii clinical trial Comparing recombinant interferon alpha-2 vs. Hydroxyurea in MPN patients.",

author = "Knudsen, {Trine Alma} and {Lund Hansen}, Dennis and Ocias, {Lukas Frans} and {Weiss Bjerrum}, Ole and Mette Brabrand and {El Fassi}, Daniel and Mikael Frederiksen and Lasse Kj{\ae}r and {Kielsgaard Kristensen}, Thomas and Kruse, {Torben A} and Mourits-Andersen, {Hans Torben} and Peter M{\o}ller and Overgaard, {Ulrik Malthe} and Severinsen, {Marianne Tang} and Skov, {Vibe Henriette} and Jesper Stentoft and J{\o}rn Starklint and {de Stricker}, Karin and Mads Thomassen and Larsen, {Thomas Stauffer} and Hasselbalch, {Hans Carl}",

year = "2018",

month = jun,

day = "15",

language = "English",

volume = "2",

pages = "18--19",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Wiley",

number = "S1",

note = "European Hematology Association 23rd congress EHA 2018 ; Conference date: 14-06-2018 Through 17-06-2018",

}

Knudsen, TA, Lund Hansen, D, Ocias, LF, Weiss Bjerrum, O, Brabrand, M, El Fassi, D, Frederiksen, M, Kjær, L, Kielsgaard Kristensen, T, Kruse, TA, Mourits-Andersen, HT, Møller, P, Overgaard, UM, Severinsen, MT, Skov, VH, Stentoft, J, Starklint, J, de Stricker, K, Thomassen, M , Larsen, TS & Hasselbalch, HC 2018, 'Interim analysis of the Daliah trial - a randomized controlled phase iii clinical trial Comparing recombinant interferon alpha-2 vs. Hydroxyurea in MPN patients.', HemaSphere, vol. 2, no. S1, S131, pp. 18-19. <https://doi.org/10.1097/HS9.0000000000000060>

Interim analysis of the Daliah trial - a randomized controlled phase iii clinical trial Comparing recombinant interferon alpha-2 vs. Hydroxyurea in MPN patients. / Knudsen, Trine Alma; Lund Hansen, Dennis; Ocias, Lukas Frans et al.
In: HemaSphere, Vol. 2, No. S1, S131, 15.06.2018, p. 18-19.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Interim analysis of the Daliah trial - a randomized controlled phase iii clinical trial Comparing recombinant interferon alpha-2 vs. Hydroxyurea in MPN patients.

AU - Knudsen, Trine Alma

AU - Lund Hansen, Dennis

AU - Ocias, Lukas Frans

AU - Weiss Bjerrum, Ole

AU - Brabrand, Mette

AU - El Fassi, Daniel

AU - Frederiksen, Mikael

AU - Kjær, Lasse

AU - Kielsgaard Kristensen, Thomas

AU - Kruse, Torben A

AU - Mourits-Andersen, Hans Torben

AU - Møller, Peter

AU - Overgaard, Ulrik Malthe

AU - Severinsen, Marianne Tang

AU - Skov, Vibe Henriette

AU - Stentoft, Jesper

AU - Starklint, Jørn

AU - de Stricker, Karin

AU - Thomassen, Mads

AU - Larsen, Thomas Stauffer

AU - Hasselbalch, Hans Carl

PY - 2018/6/15

Y1 - 2018/6/15

M3 - Conference abstract in journal

SN - 2572-9241

VL - 2

SP - 18

EP - 19

JO - HemaSphere

JF - HemaSphere

IS - S1

M1 - S131

T2 - European Hematology Association 23rd congress EHA 2018

Y2 - 14 June 2018 through 17 June 2018

ER -